Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Zhu

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
BMC Cancer|January 28, 2025
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantationEdith Pituskin, Stephen Foulkes, Rachel J Skow, et al.
Leukemia & Lymphoma|November 9, 2024
Improvement in quality of life in MDS patients who become transfusion independent after treatmentBo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.
Leukemia|August 29, 2020
Revised 15-item MDS-specific frailty scale maintains prognostic potentialBo A Wan, Aziz Nazha, Rebecca Starkman, et al.
Future Oncology (London, England)|March 7, 2025
A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMMLGuillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
American Journal of Hematology|July 5, 2017
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systemsRena Buckstein, Enrico Balleari, Richard Wells, et al.
The Lancet. Haematology|December 22, 2023
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 studyGuillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
BMC Cancer|January 28, 2025
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantationEdith Pituskin, Stephen Foulkes, Rachel J Skow, et al.
Leukemia & Lymphoma|November 9, 2024
Improvement in quality of life in MDS patients who become transfusion independent after treatmentBo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.
Leukemia|August 29, 2020
Revised 15-item MDS-specific frailty scale maintains prognostic potentialBo A Wan, Aziz Nazha, Rebecca Starkman, et al.
Future Oncology (London, England)|March 7, 2025
A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMMLGuillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
American Journal of Hematology|July 5, 2017
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systemsRena Buckstein, Enrico Balleari, Richard Wells, et al.
The Lancet. Haematology|December 22, 2023
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 studyGuillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
Pageof 3